You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA , Breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

Recruiting
  • Stage I Breast Cancer
  • +7 more
  • Baltimore, Maryland
  • +6 more
Nov 11, 2022

Breast Cancer Trial in Boston, Cambridge (Sapacitabine, Olaparib)

Active, not recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
May 2, 2022

Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • blood sample for BRCA2 mutation detection
  • (no location specified)
Jun 1, 2023

Breast Cancer Trial in Spain (Olaparib)

Terminated
  • Breast Cancer
  • Barcelona, Spain
  • +7 more
Jan 18, 2023

Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
    Cedars-Sinai Medical Center
Feb 1, 2023

TNBC - Triple-Negative Breast Cancer Trial in Nanjing (Fluzoparib+Paclitaxel, Epirubicin+Cyclophosphamide)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Nanjing, Jiangsu, China
    JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
Apr 27, 2023

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Germline BRCA-mutated HER2-negative Breast Cancer Trial in Beijing (Camrelizumab+Fluzoparib)

Enrolling by invitation
  • Germline BRCA-mutated HER2-negative Breast Cancer
  • Beijing, Beijing, China
    Breast Cancer, Peking University People's Hospital
Nov 14, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

Recruiting
  • Breast Cancer
  • Genetic Predisposition
  • Genetic predisposition to breast cancer
  • Rome, Italy
  • +1 more
May 4, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Breast Cancer After Ovarian Cancer During and/or After Therapy:

Recruiting
  • BRCA-Associated Breast Carcinoma
  • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 9, 2023

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

Endocrine Disruptors and Life STILe in Breast Cancer Development

Recruiting
  • Breast Cancer
  • +5 more
    • Roma, Italy
      Alessandra Fabi
    Feb 25, 2023

    Breast Cancer BRCA1 Carriers: a Pilot Study

    Withdrawn
    • BRCA1 Mutation
    • +2 more
    • Mifepristone 200 MG
    • Prophylactic mastectomy
    • Carmel, Indiana
    • +1 more
    Dec 13, 2022

    Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

    Not yet recruiting
    • Breast Cancer
    • Questionnaires
    • Communication of the results of the BRCA1/2 ultra rapid test
    • (no location specified)
    Oct 26, 2023

    LYNPARZA Breast Cancer in Adjuvant Setting Japan Post-Marketing

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Jan 9, 2023

      Breast Cancer With or Without BRCA Mutation

      Recruiting
      • Breast Cancer
      • Androgen receptor status and BRCA mutation
      • Varanasi, UP, India
        Banaras Hindu University
      Jun 2, 2022

      Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

      Active, not recruiting
      • Advanced Breast Cancer
      • +2 more
      • Talazoparib Tosylate
      • Stanford, California
        Stanford University Hospitals and Clinics
      Nov 16, 2022

      Breast Tumor Female Trial in United Kingdom (Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform,

      Active, not recruiting
      • Breast Neoplasm Female
      • Digital Delivery of Pre-Genetic Testing Information via the BRCA-DIRECT Platform
      • Digital Delivery of Genetic Test Results via the BRCA-DIRECT Platform
      • Manchester, England, United Kingdom
      • +4 more
      Aug 12, 2022

      Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

      Completed
      • Breast Cancer
      • Pegylated liposomal doxorubicin
      • Tucson, Arizona
      • +1 more
      Jan 9, 2023

      BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

      Completed
      • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
      • Barretos, SP, Brazil
        Barretos Cancer Hospital
      Dec 25, 2022

      l, Laboratory and Epidemiologic Characterization of Individuals

      Completed
      • Familial Ovarian Cancer
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 31, 2022